Interleukin-1β-mediated induction of Cox-2 in the CNS contributes to inflammatory pain hypersensitivity

Vane, J. R., Bakhle, Y. S. & Botting, R. M. Cyclooxygenases 1 and 2. Annu. Rev. Pharmacol. Toxicol. 38, 97–120 (1998).

McCleskey, E. W. & Gold, M. S. Ion channels of nociception. Annu. Rev. Physiol. 61, 835–856 (1999).

Woolf, C. J. & Salter, M. W. Neuronal plasticity-increasing the gain in pain. Science 288, 1765–1768 (2000).

Dantzer, R. et al. Molecular basis of sickness behavior. Ann. NY Acad. Sci. 856, 132–138 (1998).

O'Banion, M. K. Cyclooxygenase-2: molecular biology, pharmacology, and neurobiology. Crit. Rev. Neurobiol. 13, 45–82 (1999).

Maier, J. A. M., Hlas, T. & Maciag, T. Cyclooxygenase is an immediate early gene induced by interleukin-1 in human endothelial cells. J. Biol. Chem. 265, 10805–10808 (1990).

Muth-Selbach, U. S., Tegeder, I., Brune, K. & Geisslinger, G. Acetaminophen inhibits spinal prostaglandin E2 release after peripheral noxious stimulation. Anesthesiology 91, 231–239 (1999).

Smith, C. J. et al. Pharmacological analysis of cyclooxygenase-1 in inflammation. Proc. Natl Acad. Sci. USA 95, 13313–13318 (1998).

Minami, T. et al. Characterization of EP-receptor subtypes involved in allodynia and hyperalgesia induced by intrathecal administration of prostaglandin E2 to mice. Br. J. Pharmacol. 112, 735–740 (1994).

Beiche, F., Scheuerer, S., Brune, K., Geisslinger, G. & Goppelt-Struebe, M. Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation. FEBS Lett. 390, 165–169 (1996).

Hay, C. H., Trevethick, M. A., Wheeldon, A., Bowers, J. S. & de Belleroche, J. S. The potential role of spinal cord cyclooxygenase-2 in the development of Freund's complete adjuvant-induced changes in hyperalgesia and allodynia. Neuroscience 78, 843–850 (1997).

Beiche, F., Brune, K., Geisslinger, G. & Goppelt-Struebe, M. Expression of cyclooxygenase isoforms in the rat spinal cord and their regulation during adjuvant-induced arthritis. Inflamm. Res. 47, 482–487 (1998).

Hietaranta, A. et al. Extracellular phospholipases A2 in relation to systemic inflammatory response syndrome (SIRS) and systemic complications in severe acute pancreatitis. Pancreas 18, 385–391 (1999).

Levy, R., Lowenthal, A. & Dana, R. Cytosolic phospholipase A2 is required for the activation of the NADPH oxidase associated H+ channel in phagocyte-like. Adv. Exp. Med. Biol. 479, 125–135 (2000).

Saunders, M. A. et al. Mechanisms of prostaglandin E2 release by intact cells expressing cyclooxygenase-2: evidence for a ‘two-component’ model. J. Pharmacol. Exp. Ther. 288, 1101–1106 (1999).

Safieh-Garabedian, B., Poole, S., Allchorne, A., Winter, J. & Woolf, C. J. Contribution of interleukin-1β to the inflammation-induced increase in nerve growth factor levels and inflammatory hyperalgesia. Br. J. Pharmacol. 115, 1265–1275 (1995).

Cartmell, T., Poole, S., Turnbull, A. V., Rothwell, N. J. & Luheshi, G. N. Circulating interleukin-6 mediates the febrile response to localised inflammation in rats. J. Physiol. 526, 653–661 (2000).

Fantuzzi, G. & Dinarello, C. A. Interleukin-18 and interleukin-1 beta: two cytokine substrates for ICE (caspase-1). J. Clin. Immunol. 19, 1–11 (1999).

Lashbrook, J. M. et al. Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2-inhibitors in nerve-injured rats. Pain 82, 65–72 (1999).

Yaksh, T. L. & Rudy, T. A. Analgesia mediated by a direct spinal action of narcotics. Science 192, 1357–1358 (1976).

Dirig, D. M., Konin, G. P., Isakson, P. C. & Yaksh, T. L. Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2 release. Eur. J. Pharmacol. 331, 155–160 (1997).

Southall, M. D., Michael, R. L. & Vasko, M. R. Intrathecal NSAIDS attenuate inflammation-induced neuropeptide release from spinal cord slices. Pain 78, 39–48 (1998).

Yamamoto, T. & Sakashita, Y. COX-2 inhibitor prevents the development of hyperalgesia induced by intrathecal NMDA or AMPA. NeuroReport 9, 3869–3873 (1998).

Malmberg, A. B. & Yaksh, T. L. Hyperalgesia mediated by spinal glutamate or substance P receptor blocked by spinal cyclooxygenase inhibition. Science 257, 1276–1279 (1992).

Swiergiel, A. H., Smagin, G. N., Johnson, L. J. & Dunn, A. J. The role of cytokines in the behavioral responses to endotoxin and influenza virus infection in mice: effects of acute and chronic administration of the interleukin-1-receptor antagonist (IL-1ra). Brain Res. 776, 96–104 (1997).

Yao, J. H. et al. Mice deficient in interleukin-1beta converting enzyme resist anorexia induced by central lipopolysaccaride. Am. J. Physiol. 277, R1435–R1443 (1999).

Amaya, F. et al. Diversity of expression of the sensory neuron specific TTX-resistant voltage-gated sodium ion channels SNS and SNS2. Mol. Cell. Neurosci. 15, 331–342 (2000).

Curley, J. et al. Injectable biodegradable bupivacaine/polyester microspheres. Anesthesiology 84, 1401–1410 (1996).

Bingham, C. O. et al. Low molecular weight group IIA and group V phospholipase A(2) enzymes have different intracellular locations in mouse bone marrow-derived mast cells. J. Biol. Chem. 274, 31476–31484 (1999).

Sapirstein, A., Spech, R. A., Witzgall, R. & Bonventre, J. V. Cytosolic phospholipase A2 (PLA2), but not secretory PLA2, potentiates hydrogen peroxide cytotoxicity in kidney epithelial cells. J. Biol. Chem. 271, 21505–21513 (1996).